Yamada Kazuo
Department of Psychiatry, Tokyo Women's Medical University, Medical Center East, Tokyo, Japan.
J Altern Complement Med. 2006 Oct;12(8):799-803. doi: 10.1089/acm.2006.12.799.
Kampo (Japanese traditional herbal medicine) is widely used as a complementary medicine for improving the quality of life (QOL) of patients in Japan. We investigated the efficacy of kampo therapy in improving QOL of patients with various diseases and disorders, using the World Health Organization Quality of Life Brief Scale (WHOQOL-BREF).
DESIGN, SETTING, AND PARTICIPANTS: One hundred and sixty-seven outpatients with various diseases or disorders wishing to receive kampo therapy and who had already been treated with modern medicines were recruited into the study. Patients were offered kampo formulas and modern medicines for 3 months.
Scores of WHOQOL-BREF and Clinical Global Impression (CGI) Global Improvement scale, and adverse events.
Eleven patients were "very much improved," 46 were "much improved," 59 were "minimally improved," 42 showed "no change," 7 were "minimally worse," and one was "much worse" in the CGI Global Improvement scale. The mean WHOQOL-BREF score improved significantly from 3.05 +/- 0.54 at baseline to 3.14 +/- 0.53 after 3 months (p = 0.002).
Patients presenting with various diseases and disorders were successfully treated with kampo therapy. Our results suggest that kampo therapy as a complementary medicine may improve the QOL of patients with various diseases and disorders.
汉方（日本传统草药医学）在日本作为一种辅助药物被广泛用于改善患者的生活质量（QOL）。我们使用世界卫生组织生活质量简表（WHOQOL - BREF）研究了汉方疗法对改善各种疾病和病症患者生活质量的疗效。
设计、地点和参与者：招募了167名患有各种疾病或病症且希望接受汉方疗法并已接受现代医学治疗的门诊患者参与研究。为患者提供汉方配方和现代药物，为期3个月。
WHOQOL - BREF评分、临床总体印象（CGI）总体改善量表评分以及不良事件。
在CGI总体改善量表中，11名患者“显著改善”，46名“改善很多”，59名“稍有改善”，42名“无变化”，7名“稍有恶化”，1名“恶化很多”。WHOQOL - BREF平均评分从基线时的3.05±0.54显著提高到3个月后的3.14±0.53（p = 0.002）。
患有各种疾病和病症的患者通过汉方疗法得到了成功治疗。我们的结果表明，汉方疗法作为一种辅助药物可能改善各种疾病和病症患者的生活质量。
